Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

We need a break: Bisphosphonates.

Ashish Jaiman1, Dhananjaya Sabat2, Sumit Arora1

  • 1Assistant Professor, Central Institute of Orthopaedics, Vardhman Mahavir Medical College & Associated Safdarjung Hospital, New Delhi 110029, India.

Journal of Clinical Orthopaedics and Trauma
|September 26, 2015
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-post changes in agility, balance, and functional movement during short-term functional strength and balance training in national-level Kho-Kho players.

Scientific reports·2026
Same author

Sustainable valorization of artisanal sour buttermilk using nanofiltration and spray drying.

Frontiers in nutrition·2026
Same author

The CKD-OSTEO Score: A Chronic Kidney Disease-specific Tool for Osteoporosis Risk Stratification.

TouchREVIEWS in endocrinology·2026
Same author

Quadratus Femoris Muscle Pedicle Bone Grafting in Early-Stage Osteonecrosis of Femoral Head.

Hip & pelvis·2026
Same author

Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report.

Pharmaceutics·2026
Same author

Drug Resistance in HIV Following First-line ART Failure: Insights from a Cross-sectional Study in India.

The Journal of the Association of Physicians of India·2026

Bone strength is crucial for preventing fractures, but bone density scans alone don't fully predict it. Factors beyond bone density, like remodeling potential, also determine bone strength, a fact often overlooked in osteoporosis evaluation.

Area of Science:

  • Orthopedics and Bone Biology
  • Metabolic Bone Diseases

Background:

  • Bone is a dynamic tissue essential for calcium homeostasis, repair, and structural integrity.
  • Osteoporosis, characterized by reduced bone strength and increased fracture risk, is commonly assessed using bone mineral density (BMD) via DEXA scans (T and Z scores).
  • However, BMD does not solely dictate bone strength, as demonstrated by conditions like osteopetrosis and the effects of bisphosphonate therapy.

Purpose of the Study:

  • To highlight the limitations of relying solely on bone density measurements for assessing bone strength.
  • To emphasize the importance of considering other determinants of bone strength, such as material and structural properties and remodeling potential.
  • To discuss the implications of these limitations in the context of osteoporosis evaluation and treatment, particularly concerning bisphosphonates.
Keywords:
BisphosphonatesOsteoporosis

Related Experiment Videos

Main Methods:

  • Review of existing literature on bone remodeling, bone strength determinants, and osteoporosis assessment.
  • Analysis of the relationship between bone density (BMD) and bone strength.
  • Case examples (osteopetrosis) and clinical considerations (bisphosphonate use) to illustrate the dissociation between BMD and bone strength.

Main Results:

  • Bone strength is a complex trait influenced by material properties, structural characteristics, and the bone remodeling rate.
  • Bone mineral density (BMD), while correlated with fracture risk, does not fully encompass bone strength.
  • Conditions like osteopetrosis and prolonged bisphosphonate use exemplify cases where BMD may not accurately reflect bone strength.

Conclusions:

  • Osteoporosis management should consider factors beyond DEXA scan results to accurately assess fracture risk.
  • The dynamic nature of bone remodeling and its influence on bone strength are critical aspects often underestimated.
  • Further research and clinical evaluation methods are needed to comprehensively assess bone strength and guide therapeutic decisions, especially with long-term bisphosphonate use.